天美传媒

Psychoneuroimmunology; Cytokines; IL-6; TNF; Depression

Introduction

Mental disorders like depression pose a serious public health risk. About 20% of people in some societies experience depression. Future estimates indicate a rise in the frequency of depression. Several studies have suggested a connection between the nervous system and the immune system. Cytokines control how the immune system reacts to wounds, infections, and other things. Moreover, they play a significant part in immunological responses, neurogenesis, and neuroprotection, all [1-4] of which are carried out through the mediation of macrophages and monocytes. A substantial public health concern is posed by mental illnesses like depression. In some societies, depression affects around 20% of the population. Estimates for the future point to an increase in the prevalence of depression. There may be a link between the neurological system and the immune system, according to several research.The immune systems’ response to injuries, infections, and other things is regulated by cytokines. They also have a considerable impact on immunological reactions, neurogenesis, and neuroprotection, all of which are mediated by macrophages and monocytes.

Materials and Methods

Research have demonstrated that depression can activate the immune system and cause the release of cytokines and interleukins, as well as that depression itself can provoke an increase in immune cytokines. Although depression affects natural killer cell activity and B cell and T cell multiplication, it boosts interleukin levels in the blood and boosts the immune system's cellular response. In contrast, inflammatory cytokines can cause a significant depressive episode in a patient who is physically unwell. Infections and trauma that boost levels of cytokines and interleukins cause unpleasant symptoms including fatigue, weakness, and a loss of interest in physical exercise, but more importantly, they can cause depressive [5-9] symptoms. Interleukin 6 and tumour necrosis factor are raised higher than other cytokines among the immunologic factors. It is abnormal for these cytokines to be elevated in a healthy body. In this study, we first examine how the immune system and depression are related, and then we talk about how cytokines play a role in depression and how they affect neuropeptides and brain growth factors.

Discussion

Psychoneuroimmunology

The brain and immune system communicate via two different pathways: the autonomic nervous system and neuroendocrine outflow, which is mediated by the pituitary gland. Bidirectional paths are described. For instance, Besedovsky et al. observed that changes in the hypothalamus, endocrine, and autonomic processes occur simultaneously with immune system activation. The CNS can release and receive signals from an immune system that is activated, according to data (central nervous system). Immune cells produce cytokines as they become active. In addition to controlling cellular relationships, they also influence the CNS and consequently, behavioural changes. The HPA-axis is activated by several cytokines, such as IL-1, IL-2, IL-6, interferon, and tumour necrosis factor (TNF) (hypothalamic-pituitaryadrenal). Many cytokines have an impact on the neurotransmitter system. The aforementioned pathways include dysfunction of the HPA axis, alterations in growth factors, adjustments to neuropeptides, and a loss in neurogenesis. Inflammatory cytokines may also have an effect on the targeted pathways.

Depressive state and inflammatory state

As an immune-based explanation of depression, the association between cytokines and inflammation has long been recognised. The pro-inflammatory state, which has been associated with depressivelike behaviour in both human and clinical animal experiments, is hypothesised to be characterised by an increase in pro-inflammatory cytokines (PICs) and a decrease in anti-inflammatory cytokines (AICs) based on the model previously mentioned. Hippocampal (HC) neuroplasticity impairment, HC oxidative stress augmentation, and decreased serotonin levels that result in the generation of neurotoxic serotonergic metabolites such 3-hydroxykynurenine (3-HK) and guinolinic acid are a few ways that the role of inflammation state might be addressed (QA). Clinical and pre-clinical studies have suggested that levels of PICs including TNF-, IL-6, IFN-, and IL-1B are connected to depression, according to the inflammation model that has been described in depression. Results from a rodent model showed that the threshold for depressive-like behaviour is determined as 50 g/kg of PICs, such as IL-1, IL-6, IL-2, TNF-, and IFN.

Direct infusion of the Th1-promoting cytokines IFN and IL-2 may result in a state that is phenotypically depressive, as shown by human studies and animal models. According to research by Dowlati et al., there is a connection between clinical depression and a proinflammatory condition. TNF- and IL-6 levels are higher in the group of patients with depression compared to the control group, according to this meta-analysis. Hiles et almeta-analysis .'s reveals greater IL-6 levels in depressive disorders. Moreover, a cross-sectional study involving 2415 patients revealed an increase in inflammatory markers such CRP, IL-6, and TNF. A cross-sectional study conducted by Maes et al. demonstrates a relationship between inflammatory marker levels (TNF- and IL-1) and the severity of depressive episodes. Full remission, partial resolution, and increasing tendency in chronic depression are the three main clinical outcomes following an episode of depression. Anti-inflammatory or immunological biomarkers can lessen the neuro inflammation if full or partial [9-10] resolution occurs. In prospective cohort studies, the cytokine profile of depressed individuals and a control group were examined. In compared to control subjects, the 50 MDD patients in this study who were not taking any medication had greater serum concentrations of IL-1B, IL-1Ra, IL-5, IL-6, IL-7, IL-8, IL-10, granulocyte-colony stimulating factor (G-CSF), and IFN- . Certain antidepressants, like SSRIs, are able to lower the elevated levels of IL-6 and TNF- that are present in depressed patients, but other antidepressants are unable to lower PCIs. There was an increase in the levels of circulating pro-inflammatory biomarkers in some individuals of idiopathic depression without any co-morbid illnesses. Several research on patients with idiopathic severe depression revealed elevated levels of circulating biomarkers such TNF-, IL-6, their soluble receptors, and CRP. Also, a CSF analysis of depressed patients revealed an elevation in the level of certain cytokines. In depressive participants, Levine et al. measured the CSF concentration of IL-1B, IL-6, and TNF-, as well as IL-6, their soluble receptors, and CRP. The results showed that compared to controls, sad subjects had higher concentrations of IL-1B, lower levels of IL-6, and no change in TNF-a levels.

Depression and cytokines

Cytokines and chemokines control immune responses in wounds, infections, and other stressful circumstances.

Being pleiotropic chemicals, cytokines are important in inflammatory reactions. Aside from this, they also play a noteworthy part in the processes of neurogenesis and neuro-protection. They are thought to be crucial for brain development. Cytokines can also support synaptic remodelling, neurogenesis, and neuronal integrity. However, long-term exposure to high concentrations of inflammatory cytokines can cause neuropsychiatric dysfunction, with depression being a prevalent symptom. Those with medical conditions that resulted in elevated levels of inflammatory cytokines were more likely to experience depression than the general population. The proinflammatory cytokines IL-1B, IL-6, and TNF- are well known. The most extensively studied anti-inflammatory cytokines, however, are IL-4 and IL-10. Glial cells will activate cytokines during Brain traumas such as trauma, infections, and ischemic episodes. IFN—induced depression and severe depression share several similarities. As an immunological marker, IFN- may affect the CNS directly or indirectly by triggering peripheral or central pro-inflammatory cytokines. Proinflammatory cytokines have a strong relationship with the HPA axis and hippocampus glucocorticoid receptors (GRs). Elevated levels of pro-inflammatory cytokines and GR functional resistance are said to be the most researched factors in depression. Additionally considered as a contributing component to the imbalance between oxidative stress and anti-oxidative activities in depression is neuro-inflammation. According to recent study, cytokines and GRs play a significant role in the inflammatory and endocrine processes that lead to depression.

Proteins in the acute phase and major depression

There is a connection between sadness and the immune system, according to a number of documents. C4, IL-6, and C-reactive protein levels were found to be significantly higher in individuals with depressive illness, according to a study on the acute phase proteins in major depression. There is evidence that depression alters the amount of acute phase proteins. These investigations discovered a rise in the concentration of a1-acid glycoprotein. Immune system activation, cellular activity, an increase in positive acute phase proteins, and a decrease in negative acute phase proteins have all been linked to MDD.

Conclusions

Although both favourable and unfavourable results of raised cytokines have been discussed above, there appears to be a correlation between levels of pro-inflammatory cytokines such TNF- and IL-6 in individuals with severe depressive disorder. There have been reports of elevated C4 and CRP levels in MDD sufferers when it comes to acute phase proteins. To determine the precise effects of cytokines on the occurrence of depression, observational studies like cohorts should be necessary. Although many clinical studies are conducted to evaluate the relationship of inflammatory factors and depression, the majority of them are cross-sectional studies, making it difficult to determine whether these factors are one of the causes of depression or whether depression increases them.

1. Schuler BR, Fowler B, Rubio D, Kilby S, Wang Y, et al.  (2019) . J Nutr Educ Behav 51:958-966.

, ,

2. Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, et al.  (2014) . J Cyst Fibros 13: S23-S42.

, ,

3. Lucas JE, Richter LM, Daelmans B (2018) . Child Care Health Dev 44:41-49.

, ,

4. Goetz M A, Nissen H (2005) . J Nurs Educ 44:277-279.

, ,

5. Ellis WR, Dietz W H (2017) . Acad Pediatr 17:S86-S93.

, ,

6. Somberg J (2009) Am J Ther 16:281-282.

, ,

7. Wahner-Roedler DL, Knuth P, Juchems RH (1997) Mayo Clin Proc 72:pp. 1061-1068.

, ,

8. McNally, EM (2009)  J Clin Invest 119:1-10.

, ,

9. Weinstein JN (2016)  Spine 41:1-2.

, ,

10. Marshall E C (1989) Assurance of quality vision care in alternative health care delivery systems. J Am Optom Assoc 60:827-831.

,